Hi all,
My dad just had his RALP and I have heard genomic testing is useful for someone with very high-risk PCa. That being said, is there any difference between doing genomic testing now (using the post-operative prostate tissue), vs. doing it through blood sample in the future, when needed?
The urologist doesn't seem to care too much about the testing, so I think dad is being hesitant spending $$$ right now, especially after the cash outflow from the RALP. I'm just afraid that we may miss this window of opportunity, as there will be no prostate tissue to do the genomic testing in the future.
Thanks.